维生素K与抑郁症患者自杀企图之间的关联:一项案例对照研究
Shao-Ting Wang1, Xiao-Yun He1, Juan Le1
1Department of Clinical Laboratory, Institute of Translational Medicine, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, People's Republic of China.
Journal of inflammation research
|June 3, 2024
概括
低维生素K水平与抑郁症患者的自杀尝试有关. 这表明,维生素K缺乏可能是抑郁症和自杀行为的生物学风险因素.
科学领域:
- 生物化学 生物化学
- 精神病学是一个精神病学.
- 流行病学 流行病学
背景情况:
- 关于低维生素K和抑郁症/自杀之间的联系的流行病学数据有限.
- 以前的研究表明,维生素K缺乏与心理健康状况之间存在潜在的关联.
研究的目的:
- 调查抑郁症患者队列中维生素K水平和自杀企图之间的关系.
- 为了确定维生素K缺乏是否是抑郁症中自杀行为的重要危险因素.
主要方法:
- 进行了一项回顾性横截面研究.
- 参与者包括146名有自杀尝试史的个人和149名没有此类历史的对照.
- 测量包括甲状腺激素,脂质样本,炎症性细胞因子和维生素水平.
主要成果:
- 试图自杀的个体表现出较低的自由甲状腺素 (FT4),总胆固醇 (TC),维生素D和维生素K水平,以及较高的C反应蛋白 (CRP) 水平.
- 维生素K在抑郁症患者中对自杀企图具有显著的诊断价值 (灵敏度=0.842,特异性=0.715).
- 血清维生素K水平被发现可以预测抑郁症患者的自杀企图 (OR=0.614,P=0.004),观察到负相关性.
结论:
- 低血清维生素K水平与被诊断患有抑郁症的患者的自杀企图有显著的相关性.
- 维生素K缺乏可能是一个可修改的生物学风险因素,有助于发展抑郁和自杀行为.
更多相关视频
04:29Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
28.6K
06:55An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
22.5K
相关概念视频
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Depressive Disorders: Etiology
67
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
67
Depression: Overview
238
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
238
G-protein Coupled Receptors
118.2K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
118.2K
Electroconvulsive Therapy
33
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
33
Antidepressant Drugs: MAOIs and Other Agents
220
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
220
